Effects of conditioned medium from LL-37 treated adipose stem cells on human fibroblast migration.
Yang. Eun-Jung EJ; Bang. Sa-Ik SI
Key Findings
- Conditioned medium from LL‑37‑treated adipose stem cells (ASCs) increases human dermal fibroblast (HDF) migration in a time‑ and dose‑dependent way.
- LL‑37 treatment raises SDF‑1α levels in ASC‑derived medium, and blocking SDF‑1α reduces the migration effect.
- Fibroblasts exposed to this conditioned medium show higher CXCR4 expression, a receptor that guides their movement.
Practical Outcomes
- For DIY biohackers interested in skin repair, adding LL‑37 (around 10 µg/ml) to cultures of fat‑derived stem cells could generate a bio‑active fluid that speeds up fibroblast migration. While extracting and applying such conditioned medium is technically demanding, the study suggests that topical LL‑37 formulations might enhance wound healing by stimulating the body’s own stem‑cell signals.
Summary
Treating fat‑derived stem cells with the antimicrobial peptide LL‑37 makes them release factors that help skin fibroblasts move faster, which is important for wound healing. The boost comes from more SDF‑1α being produced, which signals fibroblasts to migrate.
Abstract
Adipose stem cell-conditioned medium may promote human dermal fibroblast (HDF) proliferation and migration by activating paracrine peptides during the re-epithelization phase of wound healing. Human antimicrobial peptide LL-37 is upregulated in the skin epithelium as part of the normal response to injury. The effects of conditioned medium (CM) from LL-37 treated adipose stem cells (ASCs) on cutaneous wound healing, including the mediation of fibroblast migration, remain to be elucidated, therefore the aim of the present study was to determine how ASCs would react to an LL-37-rich microenvironment and if CM from LL-37 treated ASCs may influence the migration of HDFs. The present study conducted migration assays with HDFs treated with CM from LL-37 treated ASCs. Expression of CXC chemokine receptor 4 (CXCR4), which controls the recruitment of HDFs, was analyzed at the mRNA and protein levels. To further characterize the stimulatory effects of LL-37 on ASCs, the expression of stromal cell-derived factor-1α (SDF-1α), a CXC chemokine, was investigated. CM from LL-37-treated ASCs induced migration of HDFs in a time- and dose-dependent manner, with a maximum difference in migration observed 24 h following stimulation with LL-37 at a concentration of 10 µg/ml. The HDF migration and the expression of CXCR4 in fibroblasts was markedly increased upon treatment with CM from LL-37-treated ASCs compared with CM from untreated ASCs. SDF-1α expression was markedly increased in CM from LL-37 treated ASCs. It was additionally observed that SDF-1α blockade significantly reduced HDF migration. These findings suggest the feasibility of CM from LL-37-treated ASCs as a potential therapeutic for human dermal fibroblast migration.
Study Information
pubmed
2017
2017-06-07T00:00:00.000Z
10.3892/etm.2017.4558
7
26